Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $91,445 | 27 | 99.9% |
| Food and Beverage | $48.72 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $91,445 | 27 | $0 (2024) |
| ABIOMED | $26.24 | 1 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $22.48 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $49,761 | 17 | PFIZER INC. ($49,735) |
| 2023 | $41,710 | 11 | PFIZER INC. ($41,710) |
| 2019 | $22.48 | 1 | Bayer HealthCare Pharmaceuticals Inc. ($22.48) |
All Payment Transactions
29 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | PFIZER INC. | ELREXFIO (Drug) | Consulting Fee | Cash or cash equivalent | $1,755.00 | General |
| Category: ONCOLOGY | ||||||
| 11/26/2024 | PFIZER INC. | ELREXFIO (Drug) | Consulting Fee | Cash or cash equivalent | $405.00 | General |
| Category: ONCOLOGY | ||||||
| 10/23/2024 | PFIZER INC. | ELREXFIO (Drug) | Consulting Fee | Cash or cash equivalent | $5,805.00 | General |
| Category: ONCOLOGY | ||||||
| 10/23/2024 | PFIZER INC. | ELREXFIO (Drug) | Consulting Fee | Cash or cash equivalent | $135.00 | General |
| Category: ONCOLOGY | ||||||
| 09/20/2024 | PFIZER INC. | ELREXFIO (Drug) | Consulting Fee | Cash or cash equivalent | $7,150.00 | General |
| Category: ONCOLOGY | ||||||
| 08/28/2024 | PFIZER INC. | ELREXFIO (Drug) | Consulting Fee | Cash or cash equivalent | $8,235.00 | General |
| Category: ONCOLOGY | ||||||
| 08/13/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $26.24 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/01/2024 | PFIZER INC. | ELREXFIO (Drug) | Consulting Fee | Cash or cash equivalent | $270.00 | General |
| Category: ONCOLOGY | ||||||
| 08/01/2024 | PFIZER INC. | ELREXFIO (Drug) | Consulting Fee | Cash or cash equivalent | $135.00 | General |
| Category: ONCOLOGY | ||||||
| 07/18/2024 | PFIZER INC. | ELREXFIO (Drug) | Consulting Fee | Cash or cash equivalent | $1,485.00 | General |
| Category: ONCOLOGY | ||||||
| 06/26/2024 | PFIZER INC. | ELREXFIO (Drug) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: ONCOLOGY | ||||||
| 06/13/2024 | PFIZER INC. | ELREXFIO (Drug) | Consulting Fee | Cash or cash equivalent | $2,700.00 | General |
| Category: ONCOLOGY | ||||||
| 05/10/2024 | PFIZER INC. | ELREXFIO (Drug) | Consulting Fee | Cash or cash equivalent | $3,645.00 | General |
| Category: ONCOLOGY | ||||||
| 04/04/2024 | PFIZER INC. | ELREXFIO (Drug) | Consulting Fee | Cash or cash equivalent | $3,780.00 | General |
| Category: ONCOLOGY | ||||||
| 03/22/2024 | PFIZER INC. | ELREXFIO (Drug) | Consulting Fee | Cash or cash equivalent | $2,160.00 | General |
| Category: ONCOLOGY | ||||||
| 02/02/2024 | PFIZER INC. | ELREXFIO (Drug) | Consulting Fee | Cash or cash equivalent | $3,780.00 | General |
| Category: ONCOLOGY | ||||||
| 01/19/2024 | PFIZER INC. | ELREXFIO (Drug) | Consulting Fee | Cash or cash equivalent | $7,695.00 | General |
| Category: ONCOLOGY | ||||||
| 11/30/2023 | PFIZER INC. | ELREXFIO (Drug) | Consulting Fee | Cash or cash equivalent | $7,020.00 | General |
| Category: ONCOLOGY | ||||||
| 09/21/2023 | PFIZER INC. | ELREXFIO (Drug) | Consulting Fee | Cash or cash equivalent | $2,695.00 | General |
| Category: ONCOLOGY | ||||||
| 08/23/2023 | PFIZER INC. | ELREXFIO (Drug) | Consulting Fee | Cash or cash equivalent | $2,970.00 | General |
| Category: ONCOLOGY | ||||||
| 08/10/2023 | PFIZER INC. | ELREXFIO (Drug) | Consulting Fee | Cash or cash equivalent | $3,375.00 | General |
| Category: ONCOLOGY | ||||||
| 07/07/2023 | PFIZER INC. | ELREXFIO (Drug) | Consulting Fee | Cash or cash equivalent | $2,835.00 | General |
| Category: ONCOLOGY | ||||||
| 06/01/2023 | PFIZER INC. | ELREXFIO (Drug) | Consulting Fee | Cash or cash equivalent | $7,695.00 | General |
| Category: ONCOLOGY | ||||||
| 05/05/2023 | PFIZER INC. | ELREXFIO (Drug) | Consulting Fee | Cash or cash equivalent | $3,915.00 | General |
| Category: ONCOLOGY | ||||||
| 04/05/2023 | PFIZER INC. | ELREXFIO (Drug) | Consulting Fee | Cash or cash equivalent | $1,215.00 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 44 | 1,879 | 1,981 | $290,516 | $60,992 |
| 2022 | 52 | 2,627 | 2,843 | $383,575 | $83,925 |
| 2021 | 35 | 1,401 | 1,475 | $156,113 | $37,275 |
| 2020 | 30 | 1,190 | 1,251 | $133,967 | $32,651 |
All Medicare Procedures & Services
161 procedure records from CMS Medicare Utilization — Page 7 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 73721 | Mri scan of leg joint | Facility | 2020 | 11 | 12 | $2,736 | $487.78 | 17.8% |
| 76700 | Ultrasound of abdomen | Facility | 2020 | 12 | 12 | $1,680 | $326.26 | 19.4% |
| 76536 | Ultrasound of head and neck | Facility | 2020 | 13 | 14 | $1,330 | $248.58 | 18.7% |
| 73502 | X-ray of hip with pelvis, 2-3 views | Facility | 2020 | 25 | 27 | $810.00 | $198.78 | 24.5% |
| 73030 | X-ray of shoulder, minimum of 2 views | Facility | 2020 | 24 | 28 | $896.00 | $182.76 | 20.4% |
| 72110 | X-ray of lower and sacral spine, minimum of 4 views | Facility | 2020 | 15 | 15 | $795.00 | $146.65 | 18.4% |
| 93971 | Ultrasound scan of veins of one arm or leg or limited including assessment of compression and functional maneuvers | Facility | 2020 | 11 | 11 | $891.00 | $141.96 | 15.9% |
| 74018 | X-ray of abdomen, 1 view | Facility | 2020 | 16 | 16 | $432.00 | $109.50 | 25.3% |
| 73130 | X-ray of hand, minimum of 3 views | Facility | 2020 | 12 | 16 | $512.00 | $105.50 | 20.6% |
| 72100 | X-ray of lower and sacral spine, 2 or 3 views | Facility | 2020 | 11 | 11 | $495.00 | $89.70 | 18.1% |
| 73630 | X-ray of foot, minimum of 3 views | Facility | 2020 | 16 | 17 | $544.00 | $89.10 | 16.4% |
About Dr. Frank Simone, MD
Dr. Frank Simone, MD is a Diagnostic Radiology healthcare provider based in Indiana, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1932159084.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Frank Simone, MD has received a total of $91,494 in payments from pharmaceutical and medical device companies, with $49,761 received in 2024. These payments were reported across 29 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($91,445).
As a Medicare-enrolled provider, Simone has provided services to 7,097 Medicare beneficiaries, totaling 7,550 services with total Medicare billing of $214,843. Data is available for 4 years (2020–2023), covering 161 distinct procedure/service records.
Practice Information
- Specialty Diagnostic Radiology
- Other Specialties Body Imaging, Nuclear Radiology
- Location Indiana, PA
- Active Since 05/11/2006
- Last Updated 01/14/2015
- Taxonomy Code 2085R0202X
- Entity Type Individual
- NPI Number 1932159084
Products in Payments
- ELREXFIO (Drug) $91,445
- Impella (Device) $26.24
- Gadavist (Drug) $22.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Diagnostic Radiology Doctors in Indiana
Jongwon Lee, Md, MD
Diagnostic Radiology — Payments: $3,610
Dr. Francisca Oyedeji, Md, MD
Diagnostic Radiology — Payments: $227.63
Mark Henck, Md, MD
Diagnostic Radiology — Payments: $20.95
Dominic Antico, Md, MD
Diagnostic Radiology
Govindaraj Mohan, Md, MD
Diagnostic Radiology